Iradimed Corp. (IRMD) Tops Q3 EPS by 3c

Iradimed Corp. (NASDAQ: IRMD) reported Q3 EPS of $0.14, $0.03 better than the analyst estimate of $0.11. Revenue for the quarter came in at $7.7 million versus the consensus estimate of $7.5 million.

GUIDANCE:

Iradimed Corp. sees Q4 2016 EPS of $0.04-$0.06, versus the consensus of $0.06. Iradimed Corp. sees Q4 2016 revenue of $6.5-6.7 million, versus the consensus of $6.6 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Schlumberger (SLB) earnings in-line, revenue beats expectations
• Wipro (WIT) Tops Q1 EPS by 1c
• Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c